FDA NDC Directory · JSON-LD · Markdown

Breo Ellipta

NDC 0173-0882 · HUMAN PRESCRIPTION DRUG · POWDER

Generic namefluticasone furoate and vilanterol trifenatate
Labeler / ManufacturerGlaxoSmithKline LLC
Marketing categoryNew Drug Application (innovator) · App NDA204275
Dosage form / routePOWDER · RESPIRATORY (INHALATION)
Active ingredientsFLUTICASONE FUROATE (200 ug/1)
VILANTEROL TRIFENATATE (25 ug/1)
Marketing started20150430
Package count2

External sources

Source: openFDA. Public-domain (CC0).